• About Pharmetheus
    • History
    • Mission & Values
    • Leadership
    • Scientific advisors
    • Our team
    • Social impact (CSR)
    • Contexts of use
      • Trial design and analysis
      • Program strategies and efficiences
      • Special/specific populations
      • Special considerations
      • Regulatory interactions
    • Pharmetheus Platforms
      • Model-Informed Drug Development
      • PBPK & PBBM
      • Pharmacometrics
      • QSP
    • Solutions
      • Milestone Analysis
      • Embedded Scientists
      • Expert Advice
      • Scientific Publication
    • Specific services
      • Model-Informed Bioequivalence 
& Biosimilarity
      • Accelerated submission
      • Concentration-QTc (C-QTc) modeling
      • Data-driven strategies for pediatric success
      • Training workshops
      • Publications
      • Case studies
      • Articles
    • Working with us
    • Open positions
    • Employee stories
    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Viviana Moroso brings scientific depth to quality control

    Viviana Moroso brings scientific depth to quality control

    Siv Jönsson develops Pharmetheus’s learning agenda

    Siv Jönsson develops Pharmetheus’s learning agenda

  • Events
  • News
  • Contact us
  1. Home
  2. Publications

Publications

Below we provide links to posters, white papers and scientific publications by Pharmetheus affiliates in chronological order. Please note that access to some publications may require a subscription.

Search publications

Publications

06.09.21

Lumenfantrine Exposure in Malnourished Children: PBPK Modeling Applied for Predictions and Dose Adjustments

PBPK & PBBM

MIDD

Specific populations

Infectious Diseases

PAGE 29 (2021) Abstr 9642.

Sjögren E, Tarning J, Jonsson EN

06.09.21

A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children

PBPK & PBBM

MIDD

Specific populations

Pharmaceutics. 2021 Feb 2;13(2):204.

Sjögren E, Tarning J, Barnes KI, Jonsson EN

06.09.21

Exposure–Safety Analyses of Nintedanib in Patients with Chronic Fibrosing Interstitial Lung Disease

Pharmacometrics

Respiratory

BMC Pulm Med. 2021Jul 21;21(1):244.

Schmid U, Weber B, Sarr C, Freiwald M

06.09.21

Exposure-Efficacy Analyses of Nintedanib in Patients with Chronic Fibrosing Interstitial Lung Disease

Pharmacometrics

Respiratory

Respir Med. 2021 Apr;180:106369.

Schmid U, Weber B, Magnusson MO, Freiwald M

06.09.21

Towards Industrialisation of Probability of Pharmacological Success (PoPS)

MIDD

Pharmacometrics

Program strategies and efficiencies

PAGE 29 (2021) Abstr 9805.

Sahota T, Bergstrand M, Milligan PA, Zamuner S, Chen C, Fairman D

06.09.21

Pharmacokinetic Modeling and Simulation Support for Age‐ and Weight‐Adjusted Dosing of Dabigatran Etexilate in Children with Venous Thromboembolism

Specific populations

Pharmacometrics

Hematology

J Thromb Haemost. 2021 May;19(5):1259-1270.

Röshammar D, Huang F, Albisetti M, Bomgaars L, Chalmers E, Luciani M, Halton J, Mitchell LG, Bergstrand M, Ibrahim MMA, Joseph D, Tartakovsky I, Gropper S, Brueckmann M, Brandão LR

06.09.21

Generalized FOCE with Pumas

Pharmacometrics

PAGE 29 (2021) Abstr 9734.

Noack A, Mogensen PK, Nyberg J, Ivaturi V

06.09.21

Population Pharmacokinetic Analysis of Etrolizumab in Patients with Moderately-to-Severely Active Ulcerative Colitis

Pharmacometrics

Gastroenterology

ACoP12 (Nov 2021) PMX-98.

Moein A, Lu T, Jönsson S, Ribbing J, Kassir N, Zhang W, Zhang R, Tang M, Oh YS, Bruno R, Zhu R

1 …232425… 34

Related content

16cefda6ef73b7faa4df913b326b6999f7619968 (1)

Science & Services

b794ade33e3aa54f89dcdaa2b69d3f48b3f73e5f (1)

Latest news

4033665f49ccf946b5c8406d016bbcdc6e406076 (1)

People & Culture


Contact

Pharmetheus AB
Kungsängstull 4 

753 19 Uppsala, Sweden

Visiting address: 

Dragarbrunnsgatan 77, 5th floor

  • LinkedIn
  • YouTube
  • Science & Services
    • Contexts of use
    • Pharmetheus Platforms
    • Solutions
    • Specific services
    • Publications
    • Case studies
  • Quick links
    • About us
    • Events
    • News
    • Careers
    • Contact us
    • Newsletter

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Gasell 2017
Gasell 2020
Gasell 2021
Gasell 2022
Gasell 2023
Gasell 2024

Copyright © Pharmetheus AB 2026

  • Whistleblower
  • Privacy Policy
  • Cookie Policy